SERA
SERA PROGNOSTICS, INC.
Key Financials
Operating Income
$-36504000
↑ 0.4%
Net Income
$-31928000
↑ 2.9%
Revenue
$81000
↑ 5.2%
Total Assets
$101.9M
↑ 40.5%
Total Liabilities
$26.5M
↑ 7.1%
EPS (Diluted)
$-0.67
↑ 32.3%
Cash & Equivalents
$3.9M
↓ 2.4%
Shareholders' Equity
$75.4M
↑ 57.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 144 | 3/24/2026 | View on SEC |
| 424B5 | 3/18/2026 | View on SEC |
| S-8 | 3/18/2026 | View on SEC |
| 10-K | 3/18/2026 | View on SEC |
| 8-K | 3/18/2026 | View on SEC |
| 4 | 3/13/2026 | View on SEC |
| 4 | 3/13/2026 | View on SEC |
| 4 | 3/13/2026 | View on SEC |
| 4 | 3/13/2026 | View on SEC |
| 4 | 3/13/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | SERA |
| Company Name | SERA PROGNOSTICS, INC. |
| CIK | 1534969 |
| Sector | Services-Medical Laboratories |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 8071 |
| SIC Description | Services-Medical Laboratories |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (801) 990-0520 |